| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
B Activation Using a Novel Gene-Targeted Enhanced GFP Reporter Gene Mouse1
Departments of
*
Medicine,
Genetics, and
Biochemistry and Biophysics, University of North Carolina, Chapel Hill, NC 27599
NF-
B is a family of transcription factors involved in regulating cell death/survival, differentiation, and inflammation. Although the transactivation ability of NF-B has been extensively studied in vitro, limited information is available on the spatial and temporal transactivation pattern in vivo. To investigate the kinetics and cellular localization of NF-B-induced transcription, we created a transgenic mouse expressing the enhanced GFP (EGFP) under the transcriptional control of NF-B cis elements (cis-NF-BEGFP). A gene-targeting approach was used to insert a single copy of a NF-B-dependent EGFP reporter gene 5' of the X-linked hypoxanthine phosphoribosyltransferase locus in mouse embryonic stem cells. Embryonic fibroblasts, hepatic stellate cells, splenocytes, and dendritic cells isolated from cis-NF-BEGFP mice demonstrated a strong induction of EGFP in response to LPS, anti-CD3, or TNF-
that was blocked by the NF-B inhibitors BAY 11-0782 and NEMO-binding peptide. Chromatin immunoprecipitation analysis demonstrated RelA binding to the cis-NF-BEGFP promoter. Adenoviral delivery of NF-B-inducing kinase strongly induced EGFP expression in the liver of cis-NF-BEGFP mice. Similarly, mice injected with anti-CD3 or LPS showed increased EGFP expression in mononuclear cells, lymph node, spleen, and liver as measured by flow cytometry and/or fluorescence microscopy. Using whole organ imaging, LPS selectively induced EGFP expression in the duodenum and proximal jejunum, but not in the ileum and colon. Confocal analysis indicated EGFP expression was primarily found in lamina propria mononuclear cells. In summary, the cis-NF-BEGFP mouse will serve as a valuable tool to address multiple questions regarding the cell-specific and real-time activation of NF-B during normal and diseased states.
This article has been cited by other articles:
|
|
 |
|
  R. A. Liberatore, S. P. Goff, and I. Nunes NF-{kappa}B activity is constitutively elevated in c-Abl null fibroblasts PNAS, October 20, 2009; 106(42): 17823 - 17828. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 David. L. Carbone, K. A. Popichak, J. A. Moreno, S. Safe, and R. B. Tjalkens Suppression of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Nitric-Oxide Synthase 2 Expression in Astrocytes by a Novel Diindolylmethane Analog Protects Striatal Neurons against Apoptosis Mol. Pharmacol., January 1, 2009; 75(1): 35 - 43. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Dave, J. S. Tilstra, K. Matsuoka, F. Li, T. Karrasch, J. K. Uno, A. R. Sepulveda, C. Jobin, A. S. Baldwin, P. D. Robbins, et al. Amelioration of Chronic Murine Colitis by Peptide-Mediated Transduction of the I{kappa}B Kinase Inhibitor NEMO Binding Domain Peptide J. Immunol., December 1, 2007; 179(11): 7852 - 7859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Karrasch, J.-S. Kim, M. Muhlbauer, S. T. Magness, and C. Jobin Gnotobiotic IL-10-/-;NF-{kappa}BEGFP Mice Reveal the Critical Role of TLR/NF-{kappa}B Signaling in Commensal Bacteria-Induced Colitis J. Immunol., May 15, 2007; 178(10): 6522 - 6532. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Ying and T. M. Monticello Modern Imaging Technologies in Toxicologic Pathology: An Overview Toxicol Pathol, December 1, 2006; 34(7): 815 - 826. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Yang, S. T. Magness, R. Bataller, R. A. Rippe, and D. A. Brenner NF-{kappa}B activation in Kupffer cells after partial hepatectomy Am J Physiol Gastrointest Liver Physiol, September 1, 2005; 289(3): G530 - G538. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
